Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390455
Status:
COMPLETED
Last Update Posted:
2019-12-20
First Post:
2006-10-18
Brief Title:
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Estrogen Receptor Positive |
| HER2 Positive Breast Carcinoma |
| HER2Neu Negative |
| Progesterone Receptor Positive |
| Recurrent Breast Carcinoma |
| Stage IIIB Breast Cancer AJCC v7 |
| Stage IIIC Breast Cancer AJCC v7 |
| Stage IV Breast Cancer AJCC v6 and v7 |
Keywords: